Literature DB >> 14679035

The second murine autoantibody workshop: remarkable interlaboratory concordance for radiobinding assays to identify insulin autoantibodies in nonobese diabetic mice.

Liping Yu1, George Eisenbarth, Ezio Bonifacio, James Thomas, Mark Atkinson, Clive Wasserfall.   

Abstract

In October 2000, the First Murine Autoantibody Workshop was held as part of an International Workshop on Lessons from Animal Models for Human Type 1 Diabetes. This first workshop identified insulin, but not glutamic acid decarboxylase (GAD) or IA-2, as specific autoantigens of humoral immunity in nonobese diabetic (NOD) mice. The goals of the Second Murine Autoantibody Workshop, part of the Sixth Annual Meeting of the IDS, were to increase the number of participating investigators, attempt standardization of insulin autoantibody (IAA) results across laboratories, identify serologic evidence of humoral immunity to other beta cell antigens, and allow for validation of ELISA assays for autoantibody detection in NOD mice. Sixty-three coded samples (26 pooled NOD sera, 23 pooled C57BL/6 sera, and 14 diluted samples of an anti-insulin monoclonal antibody) were distributed to 12 participating laboratories. This second workshop demonstrated that, for nearly all laboratories, IAA measured by radioimmunoassay (RIA) provided a sensitive and specific assay capable of distinguishing diabetes-prone from nondiabetes-prone mice. Analyses involving the serially diluted anti-insulin monoclonal antibody offered hope that a standard reference unit for reactivity could be established. Surprisingly, two ELISA assays for IAA detection proved remarkably sensitive (i.e., 65% and 92%). However, subsequent absorption studies performed after the workshop (presented at the IDS meeting) brought into question whether ELISA assays for IAA do, in reality, detect anti-insulin immunities and whether assays for GAD and IA-2 autoantibodies distinguish diabetes-prone from nondiabetes-prone mice. In sum, this workshop continued to support the notion that IAA, as determined by RIA, could provide a sensitive and specific marker of anti-beta cell immunity in NOD mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14679035     DOI: 10.1196/annals.1288.002

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

1.  Reduced diabetes in btk-deficient nonobese diabetic mice and restoration of diabetes with provision of an anti-insulin IgH chain transgene.

Authors:  Peggy L Kendall; Daniel J Moore; Chrys Hulbert; Kristen L Hoek; Wasif N Khan; James W Thomas
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

2.  Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes.

Authors:  David A Ostrov; Aimon Alkanani; Kristen A McDaniel; Stephanie Case; Erin E Baschal; Laura Pyle; Sam Ellis; Bernadette Pöllinger; Katherine J Seidl; Viral N Shah; Satish K Garg; Mark A Atkinson; Peter A Gottlieb; Aaron W Michels
Journal:  J Clin Invest       Date:  2018-04-03       Impact factor: 14.808

3.  Peripherin-reactive antibodies in mouse, rabbit, and human blood.

Authors:  Alexander Strom; Brigitte Sonier; Harold D Chapman; Majid Mojibian; Gen-Sheng Wang; Cristina R Slatculescu; David V Serreze; Fraser W Scott
Journal:  J Proteome Res       Date:  2010-03-05       Impact factor: 4.466

4.  Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein.

Authors:  Kevin C O'Connor; Heiner Appel; Lisa Bregoli; Matthew E Call; Ingrid Catz; Jennifer A Chan; Nicole H Moore; Kenneth G Warren; Susan J Wong; David A Hafler; Kai W Wucherpfennig
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

5.  Murine high specificity/sensitivity competitive europium insulin autoantibody assay.

Authors:  Naru Babaya; Edwin Liu; Dongmei Miao; Marcella Li; Liping Yu; George S Eisenbarth
Journal:  Diabetes Technol Ther       Date:  2009-04       Impact factor: 6.118

6.  Distinguishing persistent insulin autoantibodies with differential risk: nonradioactive bivalent proinsulin/insulin autoantibody assay.

Authors:  Liping Yu; Dongmei Miao; Laura Scrimgeour; Kelly Johnson; Marian Rewers; George S Eisenbarth
Journal:  Diabetes       Date:  2011-11-28       Impact factor: 9.461

7.  Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B:9-23 in autoimmune diabetes.

Authors:  Janet M Wenzlau; James E DiLisio; Gene Barbour; Mylinh Dang; Anita C Hohenstein; Maki Nakayama; Thomas Delong; Rocky L Baker; Kathryn Haskins
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

8.  Early childhood infections and the risk of islet autoimmunity: the Diabetes Autoimmunity Study in the Young (DAISY).

Authors:  Janet K Snell-Bergeon; Jennifer Smith; Fran Dong; Anna E Barón; Kathy Barriga; Jill M Norris; Marian Rewers
Journal:  Diabetes Care       Date:  2012-10-05       Impact factor: 19.112

9.  Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice.

Authors:  Wilma L Suarez-Pinzon; Robert F Power; Yanhua Yan; Clive Wasserfall; Mark Atkinson; Alex Rabinovitch
Journal:  Diabetes       Date:  2008-10-03       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.